Revised SPC: Tasigna (nilotinib) Hard Capsules- all strengths

SPC has been updated with warning about the combination of nilotinib with those statins that are mainly eliminated by CYP3A4, may increase the potential for statin-induced myopathy, including rhabdomyolysis.

Source:

electronic Medicines compendium